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1. Introduction 
Tissue or organ loss resulting from traumatic or non-traumatic destruction causes major 
health problems, severely affecting patient’s quality and length of life. Traditionally surgical 
treatment offers use of autologous tissues from a second site to repair or replace the 
functions of affected tissues or organs, with various outcomes. For some organs, including 
kidney, liver and pancreas, allogenic transplantation allows for functional restoration. 
However, the supply of allografts is limited and long waiting lists for tissue and organ 
transplantations indicate the need for new strategies to overcome the limitations of 
traditional therapies. 
Tissue engineering (TE), one of the major approaches of regenerative medicine, is a rapidly 
growing and exciting field of research. In combination with better understanding of 
structure, biology and physiology cell culture techniques or TE may offer new treatment 
options for patients needing replacement or repair of an organ. The principle is to dissociate 
cells from a tissue biopsy, to expand these cells in culture, and to seed them onto the scaffold 
material in vitro in order to form a live tissue construct prior to reimplantation into the 
recipient’s organism. In the appropriate biochemical and biomechanical environment these 
tissues will achieve their full functional potential and serve as native tissue equivalents. The 
TE approach has major advantages over traditional organ transplantation. Tissues that 
closely match the patient’s needs can be reconstructed from a generally readily obtainable 
biopsy. Moreover the new reconstruct can be transplanted into the patient’s body without 
donor site morbidity and with minimal or no immunogenicity. This eventually conquers 
several limitations, encountered in tissue transplantation approaches.  
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1.1 Urinary bladder disease 
Severe bladder dysfunction can be induced by disease or surgical intervention altering the 
normal pattern of storage and voiding. This might then lead to an unstable, a non-compliant 
or a smaller bladder that cannot hold normal volumes of urine. Bladder failure can result in 
clinical problems ranging from mild to severe chronic urinary incontinence leading to 
irreversible kidney damage caused by increased upper urinary tract pressure. Severe cases 
of bladder failure typically do not respond to the most conservative treatment options such 
as bladder retraining or anticholinergic medications and severely affects the patient’s 
quality of life. Currently, the treatment of choice in these patients is an enterocystoplasty, a 
surgical enlargement of the bladder using intestinal tissue. The primary aim of the surgical 
reconstruction is to increase bladder capacity and compliance. This improves continence, 
reduces intravesical storage pressure and thereby protects the upper urinary tract but fails 
to restore emptying function. Furthermore, enterocystoplasty is associated with numerous 
complications such as metabolic disturbance, increased mucus production, urolithiasis, 
infections and even malignant diseases. Many alternative sources of materials for 
reconstruction have been proposed to avoid the above mentioned complications however so 
far with only limited success. 
 
1.2 Application 
Tissue engineering, using autologous cells for implantation might offer a solution to this 
problem. Recently, several studies have confirmed feasibility of bladder reconstruction 
using engineered segments which were formed using biomaterials seeded with autologous 
cells in vitro (Yoo, Meng et al. 1998; Atala, Bauer et al. 2006, Oberpenning, Meng et al. 1999). 
This basic approach was first examined in a canine subtotal cystectomy model, where 
bladder constructs configured from natural or synthetic scaffolds and seeded with expanded 
autologous bladder-derived cells were successfully implanted (Yoo, Meng et al. 1998). This 
approach provided improved findings when compared with earlier attempts. Encouraged 
by the promising results of several animal studies, a similar approach was applied more 
recently to a small series of patients with severe neuropathic bladder dysfunction by Antony 
Atala et al. in 2006 (Atala, Bauer et al. 2006). They reported the results of 7 patients aged 4 to 
19 years, with a mean follow up of 4 years. All three patients with the engineered tissues 
made with composite-scaffolds (collagen-PGA) showed a significant increase in bladder 
capacity and compliance. Tissue biopsies of the engineered bladder segments were 
described as showing an adequate structural architecture and phenotype of the different 
cells. Although some patients benefit was reported, clinical improvement was minimal. So 
far efficacy of this novel approach does not compare favorable with conventional 
reconstruction methods using bowel segments as source of material. To date, the clinical 
application of engineered tissues has been hampered by slow vascularization, poor nutrition 
leading to cell death and consecutive tissue fibrosis (Oberpenning, Meng et al. 1999, Ko, 
Milthorpe et al. 2007). For successful bladder reconstruction revascularization of the 
construct is essential to support short and long term survival. Furthermore, to restore 
physiological bladder function reinnervation is indispensable. 
The concept of tissue engineering has been applied clinically for a variety of disorders, for 
example artificial skin for burn patients (Metcalfe and Ferguson 2007), cartilage for knee-
replacement procedures (Brittberg, Lindahl et al. 1994), injectable chondrocytes for the 
treatment of vesico-ureteric reflux (Atala, Cima et al. 1993, Caldamone and Diamond 2001) 
 
and urinary incontinence (Bent, Tutrone et al. 2001, Chancellor, Yokoyama et al. 2000). For 
hollow organs such as bladder, urethra, oesophagus, intestine, vagina, or blood vessels the 
strategies generally include implantation of either a biomaterial, which subsequently 
becomes integrated into the host organism through immigration of cells from surrounding 
tissues, or, with the technical advances in TE preferably an in vitro precombined construct 
of materials and cells. The basic requirements to achieve functional tissue are proper 
scaffolds, a suitable environment and appropriate cells. 
The ambitious goal to reconstruct a functional, contractile bladder responsive to voluntary 
control is an ongoing challenge for the future. Our ability to use donor tissue efficiently, to 
provide the optimal conditions for cultivation, long-term survival, differentiation and 
growth will lay the foundation for success. 
 
1.3 Scaffold 
The purpose of the scaffold is to serve as a temporary supporting structure allowing not 
only 3-dimensional support of tissue growth and formation but also providing the biological 
environment needed for cellular growth, differentiation and tissue formation. 
In the early days of TE stiff or non-compliant materials have been investigated for their use 
in tissue engineering. These materials were not suitable to support the formation of healthy 
tissue due to biomechanical failure and biological incompatibility (Kudish 1957, Bono and 
De Gresti 1966 Fujita 1978). 
The ideal biomaterial for hollow organs should therefore possess adequate mechanical, 
biomechanical and physical properties while being non-toxic, biocompatible, promoting 
cellular interactions and tissue development. 
Two main classes of scaffold materials have been utilized for the engineering of hollow 
organs; acellular matrices derived from donor tissues, (e.g., bladder submucosa and small 
intestinal submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic 
acid (PLA), and poly(lactic-co-glycolic acid) (PLGA). The use of composite scaffolds, 
composed of acellular matrices together with synthetic polymers for bladder reconstruction 
is promising, as it combines the advantages of the two types of materials. These different 
strategies will be discussed in detail later in this chapter. 
 
1.4 Environment 
Successful TE approaches depend on meeting a variety of critical experimental conditions. 
One is to create an environment conductive to cell growth, differentiation and eventually 
enabling the integration of an implanted TE-construct with the surrounding host tissue. In 
order to achieve this, the TE-constructs shouldn’t induce an immune response i.e. the host 
cells do not recognize it as a foreign body. Furthermore TE-constructs aim to mimique 
mechanical and biochemical properties of the native extracellular matrix (ECM). The ECM is 
the optimized natural milieu that directs tissue development and maintains tissue 
homeostasis. The ECM refers to a complex network of molecules that provide 2D- or 3D-
mechanical support for cells, serves as a barrier between different compartments or cell 
types and provides guidance cues during development, tissue repair or wound healing. On 
the individual cell basis ECM induces cell polarity, allows or inhibits cell adhesion, 
promotes or slows down migration and induces cell and tissue differentiation and might 
also induce programmed cell death (Cheresh and Stupack 2008). The ECM is composed of 
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chemically very different macromolecules that are assembled into organized structures 
remaining in close association with the surface of the cells that secreted them. The main 
components are space filling proteoglycans, containing collagen fibers and non-collagenous 
glycoproteins such as elastin. Integrated into this hydrogel-like matrix are signaling 
molecules such as growth factors, cytokines and hormones (Schonherr and Hausser 2000, 
Uebersax, Merkle et al. 2009). The ECM occurs in many different forms depending on the 
requirements of the surrounding tissue. In many cases it is a 3D-strucuture of ECM 
surrounding cells which maintains the tissue specific 3D-architecture. In other cases ECM 
forms flexible sheet-like structures between 40-120 nm thickness that serve as solid support 
layers composed of network forming laminin-entactin complexes, type IV collagen and 
heapran sulphate proteoglycans. This sheet-like ECM called basal lamina is frequently 
found in hollow organs such as blood vessels or bladder tissue. The ECM is tissue specific 
and the components self assemble to form spontaneous 2D- or 3D-structures under 
physiological conditions. Therefore, a great effort has been made to understand the 
appropriate biological, physical, and chemical cues, with the aim to mimic the ECM to guide 
morphogenesis in tissue repair (Ghosh and Ingber 2007). 
Moreover, the ECM is constantly changing in composition and structure as tissues develop, 
remodel, repair, and age (Furth, Atala et al. 2007). All body cells, except the blood cells 
interact directly and in a very specific manner with their surrounding ECM. Specific 
receptor-ligand contacts are established that enable mutual communication between the 
ECM and the interior of the cell thus regulating matrix assembly, specific remodeling and 
local removal or disassembly of the matrix (Ghosh and Ingber 2007). Cell-matrix contacts are 
mainly formed between different integrins assembled into giant transmembrane protein 
complexes that regulate and specify their ligand binding affinity as well as matrix assembly. 
Integrins are transmembrane heterodimeric glycoproteins consisting of one α and one β 
subunit forming at least 24 integrin-heterodimers known in humans. Many integrins require 
divalent cations (Ca2+, Mg2+ or Mn2+) for structural integrity and ligand binding as well as 
activation through cluster formation in order to be fully functional (Hynes 2002, Yamada 
and Even-Ram 2002, Luo and Springer 2006, Takada, Ye et al. 2007, Banno and Ginsberg 
2008, Moser, Legate et al. 2009). Although many cell-matrix contacts are formed and enable 
the cell to respond to their immediate 2D- or 3D-environment, these contacts are transient 
and strongly regulated. After implantation of a TE-construct cell-matrix interactions are 
governed by surface properties of the scaffold material and their imperative interactions 
found to occur. In addition to these cell-matrix interactions several growth factors and 
biological molecules are also involved in cell adhesion, cell-cell communication and cell-
matrix interaction. This very complex field was covered by recent reviews (e.g. Murugan 
and Ramakrishna 2007), and will therefore not be further discussed in this chapter  
 
1.5 Cells 
The basic bricks of living organisms, the cells, are a predominant factor for successful TE. 
Tissue renewal requires an adequate number of regeneration-competent cells that do not 
elicit immune response. Therefore autologous cells are the ideal choice, as their use 
circumvents many of the inflammatory and rejection issues associated with a nonself donor 
approach (Atala 2008). With the past decade, major advances in the expansion of a variety of 
primary human cells have been achieved. The different types of cells commonly used for TE 
applications can be categorized as differentiated non-stem or adult cells and as 
 
undifferentiated stem cells. Each of these cell types brings along its own advantages and 
disadvantages. 
In the field of bladder reconstruction it has been shown that adult urothelial and smooth 
muscle cells can be efficiently harvested from biopsy material, expanded extensively in 
culture and reimplanted into the same host (Oberpenning, Meng et al. 1999, Zhang, 
Ludwikowski et al. 2001, Atala 2001, Yoo, Park et al. 2000). Their differentiation 
characteristics, growth requirements and other biological properties have been widely 
studied (Southgate, Hutton et al. 1994, Turner, Subramaniam et al. 2008, Ludwikowski, 
Zhang et al. 1999). However, for elderly patients or patients with extensive end stage organ 
failure, a tissue biopsy may not yield enough normal cells for expansion and 
transplantation. Therefore adult progenitor cells may not be sufficient or appropriate for 
tissue engineering and transplantation in all cases (Heath 2000). 
Although adult progenitors remain important for TE, the use of pluripotent stem cells has 
recently been recognized as a promising alternative source of cells from which the desired 
tissue can be derived. Stem cells, by definition, are immature or undifferentiated cells with 
the potential to go through numerous cycles of self-renewal, thus replenishing the pool of 
stem cells as well as to differentiate into more specialized, tissue-/organ-specific cells. Stem 
cells can be categorized into embryonic, fetal or adult cells according to their source of 
origination (NIH). 
Embryonic stem cells exhibit two remarkable properties: the ability to proliferate in an 
undifferentiated, but still pluripotent state (self-renewal), and the ability to differentiate into 
a large number of specified cells (Brivanlou, Gage et al. 2003). As their name implies, 
embryonic stem cells are derived from the early stage embryo. Although embryonic stem 
cells research is thought to have much greater potential than adult stem cells, several ethical 
and legal controversies still exist concerning their use in humans. Furthermore, embryonic 
stem cells have been shown to transdifferentiate into a malignant phenotype, forming 
teratomas (Przyborski 2005, Yang, Lin et al. 2008). 
Fetal stem cells derived form amniotic fluid and placentas have recently been described and 
represent a novel source of stem cells (De Coppi, Callegari et al. 2007). The principle stem 
cell type isolated from amniotic fluid and placentas is mesenchymal, but they have an 
expansion potential that is superior to that of adult stem cells. They are less immunogenic as 
they do not express human leukocyte antigen (HLA) and they do not form teratomas in 
vivo. Fetal stem cells are multipotent and they have been shown do differentiate into 
myogenic, adipogenic, osteogenic, nephrogenic, neural, and endothelial cells. In addition, 
the cells have a high replicative potential and could be stored for future use, without the risk 
of rejection and without ethical concerns (Fauza 2004). 
Adult stem cells are basically undifferentiated cells found among differentiated cells in a 
tissue or organs. They are present in all adult tissues and are critical to tissue health, 
maintenance, and response to injury or disease throughout life. When compared with 
embryonic stem cells adult stem cells are more committed but still have the plasticity to 
differentiate into all three germ layers (Eberli and Atala 2006). However, they demonstrate 
considerable advantages, including; stable differentiation into specific cell lineages, no 
transdifferentiation into a malignant phenotype (teratomas), no requirement for the sacrifice 
of human embryos for their isolation and no or little immune rejection. Furthermore certain 
ethical and legal issues can also be conquered. 
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Today, pluripotent stem cells, or differentiable adult stem cells, can be harvested from many 
different tissues, including bone marrow (Angele, Kujat et al. 1999, Pittenger, Mackay et al. 
1999), striated muscle (Bosch, Musgrave et al. 2000, Lee, Qu-Petersen et al. 2000), fat (Zuk, 
Zhu et al. 2001), skin (Toma, Akhavan et al. 2001), synovial membrane (De Bari, Dell'Accio 
et al. 2001), and, more recently, testicles (Guan, Nayernia et al. 2006, Kossack, Meneses et al. 
2009). These cells can differentiate into committed cells of other tissues, a feature defined as 
plasticity. This would allow for engineering of composite tissues composed of multiple cell 
types using one single source of adult stem cells. Therefore, adult stem cells are particularly 
suitable for cellular therapy and for the engineering of tissues and organs. 
Bladder reconstruction using stem cells seeded on a scaffold has recently been shown to be a 
promising alternative for bladder engineering (Chung, Krivorov et al. 2005),(Zhang, Lin et 
al. 2005, De Coppi, Callegari et al. 2007, Frimberger, Morales et al. 2006, Oottamasathien, 
Wang et al. 2007). Recent progress suggests that engineered tissues and cell based therapies 
using adult stem cells may have an expanded clinical applicability in the future and may 
represent a viable therapeutic option for those who require tissue replacement or repair. 
The most intensively investigated adult stem cells are mesenchymal stem cells (MSCs). This 
cell type holds significant promise for the engineering of musculoskeletal structures. Bone 
marrow represents the major source of MSCs. Chung et al. performed studies in a rat model 
that examined the ability of MSCs to aid in the regeneration of bladder tissue on an acellular 
matrix scaffold (Chung, Krivorov et al. 2005). The cells were seeded onto an acellular matrix 
(small intestinal submucosa) and used in bladder augmentation studies. The number of 
smooth muscle containing bundles was dramatically increased in the seeded grafts versus 
the unseeded controls, suggesting that the mesenchymal stem cells (MSCs) have 
differentiated into smooth muscle cells (SMCs) and have contributed to the regeneration of 
the graft. In a similar study Zhang et al. described the isolation and expansion of bone 
marrow MSCs from dogs for use as an alternative cellular source for autologous bladder 
grafts using small intestinal submucosa (SIS) (Zhang, Lin et al. 2005). These authors 
demonstrated the ability of MSCs to differentiate into SMCs and provide a contractile force 
on collagen matrices in vitro. MSCs also enhanced the regenerative process when seeded 
onto SIS for augmentation cystoplasty by enhancing smooth muscle bundle formation 
(Zhang, Lin et al. 2005). However, in both studies, the cells were not labeled and therefore 
were indistinguishable from cells that may have migrated in from the surrounding normal 
tissue. 
Another source of adult stem cells is fat tissue. Unlike bone marrow stem cells, which are 
difficult to isolate and relatively scarce, adipose stem cells (ASCs) are tremendously 
abundant and easily accessible (Jack, Zhang et al. 2009). Jack et al. demonstrated the 
feasibility of bladder tissue engineered from adipose stem cells. They showed that ASCs 
differentiated into bladder smooth muscle cells and showed contractile function in vivo. The 
vast availability of ASCs combined with their ease of procurement and ability to 
differentiate into contractile smooth muscle make them a competitive non-embryonic 
alternative for regeneration of the bladder and other smooth muscle tissues (Jack, Zhang et 
al. 2009). 
Although stem cells are believed to be the key factor for the future of TE, one of the major 
challenges associated with the use of these cells is to provide appropriate cellular 
environment cues that regulate cell growth and subsequent tissue formation in a controlled 
and efficient manner (Murugan and Ramakrishna 2007). A deeper understanding of the 
 
complex interplay of stem cells and environment might allow for new strategies where stem 
cells actively participate in functional tissue and organ formation. Stem cells will 
differentiate into various cell types in situ depending on the requirements of the 
regenerating tissue, or they remain stem cells that generate progeny to maintain the tissue. 
In addition stem cells could be used to secrete factors that enhance cellular ingrowth, neo-
vascularisation, and re-innervation. 
 
2. Biomaterials 
By providing a temporary supporting structure for growing cells, the scaffold is an 
important determining factor for the success of TE. Scaffold materials can be of natural or 
synthetic origin. The underlying principle for the design of scaffolds for TE is similar for 
different types of tissues. The scaffold preferably mimics the structure and biological 
functions of native ECM, both in terms of chemical composition and physical properties. 
Native ECM is a complex and dynamic environment filled with nano-features such as fibers 
displaying a certain pore size and interconnectivity that should ideally exhibit tissue-specific 
structures and properties. When naturally derived scaffolds are used they provide specific 
ligands for cell adhesion and migration, as well as various growth factors inducing specific 
cell proliferation and functions. 
Currently, a variety of materials are available for manufacturing scaffolds for TE, including 
native and synthetic polymers and their composites. The choice of material depends on the 
type of tissue to be reconstructed. Most hollow organs are organized in a similar fashion, 
consisting of epithelium surrounded by a collagen type I-rich connective tissue and a 
smooth muscle layer. The epithelial or endothelial layer serves as a barrier preventing the 
content of the lumen from permeating into the body. The collagen type-I rich layer and the 
muscle layer maintain the structural and functional integrity of the organ. The cells within 
these layers interact with each other and with structural proteins to regulate cellular 
differentiation and function (Ziats, Miller et al. 1988, Bacakova, Filova et al. 2004). 
The following characteristics are desirable for scaffolds used for TE in general.  
The scaffold should 
 be biocompatible, meaning that it should not provoke any rejection, inflammation, 
immune responses or foreign body reactions. 
 provide a 3D template for the cells to attach and to guide their growth. 
 have a porous architecture with a high surface area for the maximum loading of cells, cell-
surface interaction, tissue ingrowth, and transportation of nutrients and oxygen. 
 be degradable under physiological conditions and the degradation rate should match the 
rate of tissue regeneration to sustain tissue functionality. 
 be mechanically strong to withstand in vivo biological forces. 
 support the cells in synthesizing tissue specific extracellular matrix components and 
growth factors required for healthy tissue growth. 
 be sterilizable to avoid toxic contaminations without compromising any structural and 
mechanical properties.  
Finally, the production process of the scaffold with all the above unique characteristics must 
be accomplished in a reproducible, economical, and up-scalable manner (Murugan and 
Ramakrishna 2007). 
In respect to bladder TE the ideal scaffold material should 
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Today, pluripotent stem cells, or differentiable adult stem cells, can be harvested from many 
different tissues, including bone marrow (Angele, Kujat et al. 1999, Pittenger, Mackay et al. 
1999), striated muscle (Bosch, Musgrave et al. 2000, Lee, Qu-Petersen et al. 2000), fat (Zuk, 
Zhu et al. 2001), skin (Toma, Akhavan et al. 2001), synovial membrane (De Bari, Dell'Accio 
et al. 2001), and, more recently, testicles (Guan, Nayernia et al. 2006, Kossack, Meneses et al. 
2009). These cells can differentiate into committed cells of other tissues, a feature defined as 
plasticity. This would allow for engineering of composite tissues composed of multiple cell 
types using one single source of adult stem cells. Therefore, adult stem cells are particularly 
suitable for cellular therapy and for the engineering of tissues and organs. 
Bladder reconstruction using stem cells seeded on a scaffold has recently been shown to be a 
promising alternative for bladder engineering (Chung, Krivorov et al. 2005),(Zhang, Lin et 
al. 2005, De Coppi, Callegari et al. 2007, Frimberger, Morales et al. 2006, Oottamasathien, 
Wang et al. 2007). Recent progress suggests that engineered tissues and cell based therapies 
using adult stem cells may have an expanded clinical applicability in the future and may 
represent a viable therapeutic option for those who require tissue replacement or repair. 
The most intensively investigated adult stem cells are mesenchymal stem cells (MSCs). This 
cell type holds significant promise for the engineering of musculoskeletal structures. Bone 
marrow represents the major source of MSCs. Chung et al. performed studies in a rat model 
that examined the ability of MSCs to aid in the regeneration of bladder tissue on an acellular 
matrix scaffold (Chung, Krivorov et al. 2005). The cells were seeded onto an acellular matrix 
(small intestinal submucosa) and used in bladder augmentation studies. The number of 
smooth muscle containing bundles was dramatically increased in the seeded grafts versus 
the unseeded controls, suggesting that the mesenchymal stem cells (MSCs) have 
differentiated into smooth muscle cells (SMCs) and have contributed to the regeneration of 
the graft. In a similar study Zhang et al. described the isolation and expansion of bone 
marrow MSCs from dogs for use as an alternative cellular source for autologous bladder 
grafts using small intestinal submucosa (SIS) (Zhang, Lin et al. 2005). These authors 
demonstrated the ability of MSCs to differentiate into SMCs and provide a contractile force 
on collagen matrices in vitro. MSCs also enhanced the regenerative process when seeded 
onto SIS for augmentation cystoplasty by enhancing smooth muscle bundle formation 
(Zhang, Lin et al. 2005). However, in both studies, the cells were not labeled and therefore 
were indistinguishable from cells that may have migrated in from the surrounding normal 
tissue. 
Another source of adult stem cells is fat tissue. Unlike bone marrow stem cells, which are 
difficult to isolate and relatively scarce, adipose stem cells (ASCs) are tremendously 
abundant and easily accessible (Jack, Zhang et al. 2009). Jack et al. demonstrated the 
feasibility of bladder tissue engineered from adipose stem cells. They showed that ASCs 
differentiated into bladder smooth muscle cells and showed contractile function in vivo. The 
vast availability of ASCs combined with their ease of procurement and ability to 
differentiate into contractile smooth muscle make them a competitive non-embryonic 
alternative for regeneration of the bladder and other smooth muscle tissues (Jack, Zhang et 
al. 2009). 
Although stem cells are believed to be the key factor for the future of TE, one of the major 
challenges associated with the use of these cells is to provide appropriate cellular 
environment cues that regulate cell growth and subsequent tissue formation in a controlled 
and efficient manner (Murugan and Ramakrishna 2007). A deeper understanding of the 
 
complex interplay of stem cells and environment might allow for new strategies where stem 
cells actively participate in functional tissue and organ formation. Stem cells will 
differentiate into various cell types in situ depending on the requirements of the 
regenerating tissue, or they remain stem cells that generate progeny to maintain the tissue. 
In addition stem cells could be used to secrete factors that enhance cellular ingrowth, neo-
vascularisation, and re-innervation. 
 
2. Biomaterials 
By providing a temporary supporting structure for growing cells, the scaffold is an 
important determining factor for the success of TE. Scaffold materials can be of natural or 
synthetic origin. The underlying principle for the design of scaffolds for TE is similar for 
different types of tissues. The scaffold preferably mimics the structure and biological 
functions of native ECM, both in terms of chemical composition and physical properties. 
Native ECM is a complex and dynamic environment filled with nano-features such as fibers 
displaying a certain pore size and interconnectivity that should ideally exhibit tissue-specific 
structures and properties. When naturally derived scaffolds are used they provide specific 
ligands for cell adhesion and migration, as well as various growth factors inducing specific 
cell proliferation and functions. 
Currently, a variety of materials are available for manufacturing scaffolds for TE, including 
native and synthetic polymers and their composites. The choice of material depends on the 
type of tissue to be reconstructed. Most hollow organs are organized in a similar fashion, 
consisting of epithelium surrounded by a collagen type I-rich connective tissue and a 
smooth muscle layer. The epithelial or endothelial layer serves as a barrier preventing the 
content of the lumen from permeating into the body. The collagen type-I rich layer and the 
muscle layer maintain the structural and functional integrity of the organ. The cells within 
these layers interact with each other and with structural proteins to regulate cellular 
differentiation and function (Ziats, Miller et al. 1988, Bacakova, Filova et al. 2004). 
The following characteristics are desirable for scaffolds used for TE in general.  
The scaffold should 
 be biocompatible, meaning that it should not provoke any rejection, inflammation, 
immune responses or foreign body reactions. 
 provide a 3D template for the cells to attach and to guide their growth. 
 have a porous architecture with a high surface area for the maximum loading of cells, cell-
surface interaction, tissue ingrowth, and transportation of nutrients and oxygen. 
 be degradable under physiological conditions and the degradation rate should match the 
rate of tissue regeneration to sustain tissue functionality. 
 be mechanically strong to withstand in vivo biological forces. 
 support the cells in synthesizing tissue specific extracellular matrix components and 
growth factors required for healthy tissue growth. 
 be sterilizable to avoid toxic contaminations without compromising any structural and 
mechanical properties.  
Finally, the production process of the scaffold with all the above unique characteristics must 
be accomplished in a reproducible, economical, and up-scalable manner (Murugan and 
Ramakrishna 2007). 
In respect to bladder TE the ideal scaffold material should 
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 provide structural support for distinct cell layers, including an adequate surface for stable 
attachment of urothelial cells. 
 give adequate biomechanical support to harbor a high density of smooth muscle cells on 
the exterior surface without inducing premature collapse of the hollow organ. 
 serve as a barrier between luminal contents and the body cavity. 
 support the formation of unidirectional muscle tissue in defined layers and allow for rapid 
innervation and vascularisation. 
Since each of the different cell types favors different conditions for optimal growth and 
differentiation, tissue engineering using multiple cell types must take these factors into 
account. 
Two main classes of biomaterials have been utilized for the engineering of hollow organs; 
acellular matrices derived from donor tissues, (e.g. bladder submucosa and small intestinal 
submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 
and poly(lactic-co-glycolic acid) (PLGA). These materials have been tested in respect to their 
biocompatibility in the host tissues (Scriven, Trejdosiewicz et al. 2001; Pariente, Kim et al. 
2002). Both types of material were able to support the formation of bladder like tissue. 
Acellular tissue matrices are extracted form native tissue and therefore contain growth 
factors, hormones and other signaling factors (Ziats, Miller et al. 1988, Brown, Brook-Allred 
et al. 2005, Chun, Lim et al. 2007) that promote tissue development and have adhesion 
domain sequences (e.g. RGD) that may support the phenotype and activity of many types of 
cells (Dawson, Goberdhan et al. 1996). These matrices are known to slowly degrade upon 
implantation and are usually replaced and remodeled by ECM proteins synthesized and 
secreted by transplanted or ingrowing cells (Daniels, Chang et al. 1990; Aharoni, Meiri et al. 
1997; Ashammakhi and Rokkanen 1997; Talja, Valimaa et al. 1997; Hodde 2002; Santucci and 
Barber 2005; Daley, Peters et al. 2008; Mohamed and van der Walle 2008). In contrast, 
synthetic polymers can be manufactured reproducibly on a large scale with controlled 
properties of their strength, degradation rate and ultra structure (Hutmacher, Schantz et al. 
2007; Ma, Mao et al. 2007). Both classes of biomaterials have been used either with or 
without cells for the tissue engineering of hollow organs, including bladder (Kropp, Rippy 
et al. 1996, Yoo, Meng et al. 1998, Oberpenning, Meng et al. 1999), urethra (Olsen 1992, 
Kropp, Ludlow et al. 1998), oesophagus (Urita, Komuro et al. 2007, Penkala and Kim 2007), 
intestine (Penkala and Kim 2007), vagina (De Filippo, Yoo et al. 2003), or blood vessels 
(Amiel, Komura et al. 2006, Lee, Choo et al. 2007). 
 
2.1 Native Acellular Matrices  
Native acellular matrices are pioneering materials and offer many potential advantages over 
synthetic scaffold materials (Southgate, Cross et al. 2003). These collagen-rich matrices are 
extracted from native tissue by mechanical or chemical decellularization (Chen, Yoo et al. 
1999, Dahms, Piechota et al. 1998, Piechota, Dahms et al. 1998). They are either derived from 
bladder (bladder acellular matrix (BAM)) (Sutherland, Baskin et al. 1996) or from small 
intestine (SIS) (Kropp, Ludlow et al. 1998, Kropp, Rippy et al. 1996). The tensile backbone of 
the scaffold consists of fibrillar collagen type I, and the basement membrane, serving as a 
cyto- and tissue-compatible polymeric scaffold for recellularisation. One important 
advantage over synthetic materials is the fact that acellular matrices retain their biological 
activity. They provide specific integrin binding sites and contain endogenous growth factors 
encouraging the in-growth of tissue (Badylak 2004, Santucci and Barber 2005). Furthermore, 
 
given that the composition and structure of the ECM is unique to individual tissues, there 
may be advantages in orthotopic-derived matrices: BAM may be expected to contain more 
appropriate growth factors for bladder TE than SIS (Bolland, Korossis et al. 2007). Once 
implanted into the body, they slowly degrade supporting the ingrowth of host cells which 
then start to produce new ECM proteins. 
In bladder reconstruction acellular matrices have been used either as a graft alone or seeded 
with urothelial and smooth muscle cells (Kropp, Rippy et al. 1996; Yoo, Meng et al. 1998; 
Oberpenning, Meng et al. 1999; Sievert, Bakircioglu et al. 2000; Sievert, Amend et al. 2007, 
Probst, Piechota et al. 2000, Zhang, Frimberger et al. 2006, Reddy, Barrieras et al. 2000). 
Analysis of unseeded SIS patches after implantation in dogs showed replacement by normal 
bladder tissue, vascularisation and re-innervation (Kropp, Rippy et al. 1996). However, 
successful bladder regeneration using SIS appears to be dependent on the revascularization 
rate of the graft and the extent of the original bladder damage. SIS was not able to support 
functional tissue regeneration when used in animals with inflamed and contracted bladder 
remnants (Zhang, Frimberger et al. 2006).  
Implanting BAM into the bladder of rats, rabbits, dogs and pigs resulted in the regeneration 
of urothelial and muscle layers with innervation and vascularisation of the graft (Probst, 
Piechota et al. 2000, Sievert, Bakircioglu et al. 2000, Reddy, Barrieras et al. 2000). Moreover, 
BAM was shown to release exogenous basic fibroblast growth factor (bFGF) in a rat model 
of bladder augmentation. bFGF is an important growth factor supporting tissue formation 
and reducing graft shrinkage (Kanematsu, Yamamoto et al. 2003). 
However, problems with poor vascularisation, graft shrinkage and incomplete or 
disorganized smooth muscle development have been associated with the use of 
decellularised matrices (Zhang, Frimberger et al. 2006, Brown, Farhat et al. 2002, Kropp, 
Cheng et al. 2004). Graft shrinkage occurs due to the fast ingrowth of fibroblasts (Brown, 
Farhat et al. 2002). It seems to be a frequent finding of a scaffold when used as a graft for 
bladder or other hollow structures. Researchers agree that the larger the graft, the more 
pronounced the shrinkage due to the activity of smooth muscle actin-positive fibroblasts 
(Brown, Farhat et al. 2002, Kropp, Cheng et al. 2004). Omental coverage, endothelial cell 
seeding, or application of exogenous angiogenic growth factors were reported to allow 
ingrowth of capillaries to the graft (Kanematsu, Yamamoto et al. 2003, Baumert, Simon et al. 
2007). However, establishment and maintenance of a permanent and sufficiently robust 
vascular supply to sustain a large graft for the human bladder remains to be demonstrated. 
The above mentioned problems led to the concept of ex vivo seeding of autologous cells 
onto different scaffold materials, with the aim of enhancing tissue integration following 
implantation. This would minimize the inflammatory response toward the matrix, thus 
avoiding graft contracture and shrinkage. Yoo et al. showed that there was a major 
difference between BAM used with autologous cells and matrices used without cells (Yoo, 
Meng et al. 1998). 
A major disadvantage of these systems is the routine variability in protein composition 
among the batches. There may also be ethical issues regarding their availability, although 
most naturally derived scaffolds are porcine xenografts. 
 
2.2 Synthetic polymers 
Historically the attempt to incorporate of synthetic materials alone into the bladder has 
mostly failed, primarily as a result of biological and mechanical incompatibilities. Amongst 
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 provide structural support for distinct cell layers, including an adequate surface for stable 
attachment of urothelial cells. 
 give adequate biomechanical support to harbor a high density of smooth muscle cells on 
the exterior surface without inducing premature collapse of the hollow organ. 
 serve as a barrier between luminal contents and the body cavity. 
 support the formation of unidirectional muscle tissue in defined layers and allow for rapid 
innervation and vascularisation. 
Since each of the different cell types favors different conditions for optimal growth and 
differentiation, tissue engineering using multiple cell types must take these factors into 
account. 
Two main classes of biomaterials have been utilized for the engineering of hollow organs; 
acellular matrices derived from donor tissues, (e.g. bladder submucosa and small intestinal 
submucosa), and synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), 
and poly(lactic-co-glycolic acid) (PLGA). These materials have been tested in respect to their 
biocompatibility in the host tissues (Scriven, Trejdosiewicz et al. 2001; Pariente, Kim et al. 
2002). Both types of material were able to support the formation of bladder like tissue. 
Acellular tissue matrices are extracted form native tissue and therefore contain growth 
factors, hormones and other signaling factors (Ziats, Miller et al. 1988, Brown, Brook-Allred 
et al. 2005, Chun, Lim et al. 2007) that promote tissue development and have adhesion 
domain sequences (e.g. RGD) that may support the phenotype and activity of many types of 
cells (Dawson, Goberdhan et al. 1996). These matrices are known to slowly degrade upon 
implantation and are usually replaced and remodeled by ECM proteins synthesized and 
secreted by transplanted or ingrowing cells (Daniels, Chang et al. 1990; Aharoni, Meiri et al. 
1997; Ashammakhi and Rokkanen 1997; Talja, Valimaa et al. 1997; Hodde 2002; Santucci and 
Barber 2005; Daley, Peters et al. 2008; Mohamed and van der Walle 2008). In contrast, 
synthetic polymers can be manufactured reproducibly on a large scale with controlled 
properties of their strength, degradation rate and ultra structure (Hutmacher, Schantz et al. 
2007; Ma, Mao et al. 2007). Both classes of biomaterials have been used either with or 
without cells for the tissue engineering of hollow organs, including bladder (Kropp, Rippy 
et al. 1996, Yoo, Meng et al. 1998, Oberpenning, Meng et al. 1999), urethra (Olsen 1992, 
Kropp, Ludlow et al. 1998), oesophagus (Urita, Komuro et al. 2007, Penkala and Kim 2007), 
intestine (Penkala and Kim 2007), vagina (De Filippo, Yoo et al. 2003), or blood vessels 
(Amiel, Komura et al. 2006, Lee, Choo et al. 2007). 
 
2.1 Native Acellular Matrices  
Native acellular matrices are pioneering materials and offer many potential advantages over 
synthetic scaffold materials (Southgate, Cross et al. 2003). These collagen-rich matrices are 
extracted from native tissue by mechanical or chemical decellularization (Chen, Yoo et al. 
1999, Dahms, Piechota et al. 1998, Piechota, Dahms et al. 1998). They are either derived from 
bladder (bladder acellular matrix (BAM)) (Sutherland, Baskin et al. 1996) or from small 
intestine (SIS) (Kropp, Ludlow et al. 1998, Kropp, Rippy et al. 1996). The tensile backbone of 
the scaffold consists of fibrillar collagen type I, and the basement membrane, serving as a 
cyto- and tissue-compatible polymeric scaffold for recellularisation. One important 
advantage over synthetic materials is the fact that acellular matrices retain their biological 
activity. They provide specific integrin binding sites and contain endogenous growth factors 
encouraging the in-growth of tissue (Badylak 2004, Santucci and Barber 2005). Furthermore, 
 
given that the composition and structure of the ECM is unique to individual tissues, there 
may be advantages in orthotopic-derived matrices: BAM may be expected to contain more 
appropriate growth factors for bladder TE than SIS (Bolland, Korossis et al. 2007). Once 
implanted into the body, they slowly degrade supporting the ingrowth of host cells which 
then start to produce new ECM proteins. 
In bladder reconstruction acellular matrices have been used either as a graft alone or seeded 
with urothelial and smooth muscle cells (Kropp, Rippy et al. 1996; Yoo, Meng et al. 1998; 
Oberpenning, Meng et al. 1999; Sievert, Bakircioglu et al. 2000; Sievert, Amend et al. 2007, 
Probst, Piechota et al. 2000, Zhang, Frimberger et al. 2006, Reddy, Barrieras et al. 2000). 
Analysis of unseeded SIS patches after implantation in dogs showed replacement by normal 
bladder tissue, vascularisation and re-innervation (Kropp, Rippy et al. 1996). However, 
successful bladder regeneration using SIS appears to be dependent on the revascularization 
rate of the graft and the extent of the original bladder damage. SIS was not able to support 
functional tissue regeneration when used in animals with inflamed and contracted bladder 
remnants (Zhang, Frimberger et al. 2006).  
Implanting BAM into the bladder of rats, rabbits, dogs and pigs resulted in the regeneration 
of urothelial and muscle layers with innervation and vascularisation of the graft (Probst, 
Piechota et al. 2000, Sievert, Bakircioglu et al. 2000, Reddy, Barrieras et al. 2000). Moreover, 
BAM was shown to release exogenous basic fibroblast growth factor (bFGF) in a rat model 
of bladder augmentation. bFGF is an important growth factor supporting tissue formation 
and reducing graft shrinkage (Kanematsu, Yamamoto et al. 2003). 
However, problems with poor vascularisation, graft shrinkage and incomplete or 
disorganized smooth muscle development have been associated with the use of 
decellularised matrices (Zhang, Frimberger et al. 2006, Brown, Farhat et al. 2002, Kropp, 
Cheng et al. 2004). Graft shrinkage occurs due to the fast ingrowth of fibroblasts (Brown, 
Farhat et al. 2002). It seems to be a frequent finding of a scaffold when used as a graft for 
bladder or other hollow structures. Researchers agree that the larger the graft, the more 
pronounced the shrinkage due to the activity of smooth muscle actin-positive fibroblasts 
(Brown, Farhat et al. 2002, Kropp, Cheng et al. 2004). Omental coverage, endothelial cell 
seeding, or application of exogenous angiogenic growth factors were reported to allow 
ingrowth of capillaries to the graft (Kanematsu, Yamamoto et al. 2003, Baumert, Simon et al. 
2007). However, establishment and maintenance of a permanent and sufficiently robust 
vascular supply to sustain a large graft for the human bladder remains to be demonstrated. 
The above mentioned problems led to the concept of ex vivo seeding of autologous cells 
onto different scaffold materials, with the aim of enhancing tissue integration following 
implantation. This would minimize the inflammatory response toward the matrix, thus 
avoiding graft contracture and shrinkage. Yoo et al. showed that there was a major 
difference between BAM used with autologous cells and matrices used without cells (Yoo, 
Meng et al. 1998). 
A major disadvantage of these systems is the routine variability in protein composition 
among the batches. There may also be ethical issues regarding their availability, although 
most naturally derived scaffolds are porcine xenografts. 
 
2.2 Synthetic polymers 
Historically the attempt to incorporate of synthetic materials alone into the bladder has 
mostly failed, primarily as a result of biological and mechanical incompatibilities. Amongst 
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others polyvinyl sponges, silicone, polytetrafluoroethylene (Teflon) and resin-sprayed paper 
have been used to reconstruct the bladder with variable results, but none of the methods 
have been pursued to the present day (Kudish 1957, Bono and De Gresti 1966, Fujita 1978). 
Modern synthetic polymers such as PGA, PLA and PLGA are widely used in tissue 
engineering and have been applied in bladder reconstruction. These polymers received FDA 
approval for a variety of applications in human, including suture material. The ester bonds 
in these polymers are hydrolytically labile, thus allowing degradation by non enzymatic 
hydrolysis.  
The degradation products of PGA, PLA, and PLGA are nontoxic natural metabolites and are 
eventually eliminated from the body in the form of carbon dioxide and water (Hutmacher 
2000). The degradation rate of these polymers can be tailored from several weeks to several 
years by altering the crystalinity, initial molecular weight, and the copolymer ratio of lactic 
to glycolic acids. Since these polymers are thermoplastics, they can be easily formed into a 
3D scaffold with a desired microstructure, gross shape, and dimension by various 
techniques, including molding, extrusion (Freed, Vunjak-Novakovic et al. 1994), solvent 
casting (Mikos, Lyman et al. 1994), phase separation techniques, gas foaming techniques 
(Harris, Kim et al. 1998) and electrospinning (Bini, Gao et al. 2004, Zong, Bien et al. 2005). 
Many applications in tissue engineering require a scaffold with high porosity and high ratio 
of surface area to volume. Other biodegradable synthetic polymers, including 
poly(anhydrides) and poly(ortho-esters) can also be used to fabricate scaffolds for tissue 
engineering with controlled properties (Peppas and Langer 1994).  
Bladder-derived cells have been propagated on biodegradable synthetic scaffolds (Atala, 
Bauer et al. 2006, Oberpenning, Meng et al. 1999; Scriven, Trejdosiewicz et al. 2001; 
Danielsson, Ruault et al. 2006). Compared to natural materials, the advantage of producing 
a synthetic scaffold material is the full control over processing properties such as strength, 
biodegradability, microstructure and permeability, however, a fundamental feature of these 
materials is that they lack the natural signals that regulate cell attachment, growth and 
differentiation (Danielsson, Ruault et al. 2006, Vacanti and Langer 1999). 
Atala and colleagues first demonstrated the feasibility of cells seeding onto a purely 
synthetic matrix for implantation in vivo (Oberpenning, Meng et al. 1999). PLGA is a well 
characterized biomaterial with predictable degradation properties, which is widely used as 
Vicryl® sutures and meshes. It is non-toxic and biocompatible with both urothelial and 
bladder smooth muscle cells (Pariente, Kim et al. 2002, Scriven, Trejdosiewicz et al. 2001). 
These qualities make PLGA an attractive candidate for combination with natural materials 
to form implantable constructs for bladder reconstruction. Oberpenning et al. also used PGA 
meshes, molded into the shape of a bladder and surface-coated with PLGA. The constructs 
were seeded with autologous smooth muscle cells on the outer and urothelial cells on the 
inner surfaces of the scaffold material (Oberpenning, Meng et al. 1999). After subtotal 
cystectomy in dogs the bladder constructs were then implanted onto the bladder base 
(trigone) and the neo-bladder was then coated with fibrin glue and surrounded with 
omentum. The animals were monitored for up to 11 months. There were no complications 
and at three months, the polymer had degraded. Functionally, the reconstructed bladders 
provided an adequate capacity with good compliance. Histologically and 
immunocytochemically, the bladders showed an adequate structural architecture, and 
phenotypically, the urothelium and muscle retained their program of normal differentiation. 
 
As previously mentioned, synthetic biodegradable polymers lack the presence of extra-
cellular matrix components, and therefore of cell adhesion sequences and signaling 
molecules. However, modification of the polymer scaffolds’ chemistry and the method of 
manufacturing allow improvement of cell adherence potential, growth rate and phenotype 
regulation (Bisson, Hilborn et al. 2002, Kim, Nikolovski et al. 1999). It is essential that the 
structural features of the produced scaffolds resemble the natural ECM in order to provide 
tissue formation and promote rapid clinical translation. Recently, numerous investigations 
have explored the possibility of producing scaffolds similar to natural ECM (Yang, Murugan 
et al. 2005, Murugan and Ramakrishna 2006, Xu, Inai et al. 2004). These scaffolds possess a 
high surface area, high porosity, small pore size, and a low density, all of which are features 
essential for the improvement of cell adhesion, mandatory for cell migration, proliferation, 
and differentiation. Polymeric nanofibres matrices are among the most promising ECM-
mimetic biomaterials because their physical structure is similar to that of fibrous proteins in 
native ECM. They are increasingly being used in TE and have advantages over traditional 
scaffolds due to increased surface-to-volume ratio, which is supposed to be advantageous 
for cell-scaffold interaction promoting cellular adhesion, proliferation, migration and 
function. 
Additionally, providing a scaffold made of nanofibres may guide the growth of muscle cells 
in three dimensions. Attitude and orientation of these fibers are considered to be one of the 
important features of a functional tissue scaffold containing muscle cells. This leads to the 
concept of nano-fibrous scaffolds for tissue engineering applications. Further, fiber 
orientation of the scaffolds greatly influences cell orientation and phenotypic expression 
(Ma, Kotaki et al. 2005, Yang, Murugan et al. 2005). For instance, Xu et al. (Xu, Inai et al. 
2004) have evaluated electrospun synthetic biomaterials (poly(l-lactid-co-ε-caprolactone), 
P(LLA-CL)) using smooth muscle cells. The diameter of the generated fibers was around 
500nm with an aligned topography mimicking the circumferential orientation of cells and 
fibrils found in the medial layer of a native artery. The results show that the cells adhered 
and migrated along the axis of aligned scaffolds while expressing a spindle-like phenotype. 
The cytoskeleton organization inside these cells was also parallel to the orientation of the 
fibrous assembly. A study by Baker et al. showed that smooth muscle cells adapted a more 
natural organization when grown on electrospun polystyrene scaffolds as compared to 
collagen fibers in vivo (Baker, Atkin et al. 2006). 
Therefore, engineering scaffolds while controlling the fiber orientation is essential for 
mimicking structural and functional aspects of the native ECM, controlling cell orientation 
and tissue growth. Currently, there are a number of methods available for manufacturing 
tissue scaffolds, which include electrospinning, self-assembly, phase separation, solvent-
casting and particulate-leaching, freeze drying, melt molding, template synthesis, drawing, 
gas foaming, and solid-free forming (Murugan and Ramakrishna 2007). Among them, only 
electrospinning offers the capability to design nanofibrous scaffolds in the form of 
nonwoven structures that can meet the demands of scaffold-based tissue engineering 
applications. 
 
2.3 Composite scaffold 
Methods to improve cell attachment and proliferation on synthetic materials have already 
been explored. One approach is to coat a synthetic material with biological substances such 
as collagen, serum or to use surface modification procedures prior to cell seeding to 
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others polyvinyl sponges, silicone, polytetrafluoroethylene (Teflon) and resin-sprayed paper 
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casting and particulate-leaching, freeze drying, melt molding, template synthesis, drawing, 
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electrospinning offers the capability to design nanofibrous scaffolds in the form of 
nonwoven structures that can meet the demands of scaffold-based tissue engineering 
applications. 
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Methods to improve cell attachment and proliferation on synthetic materials have already 
been explored. One approach is to coat a synthetic material with biological substances such 
as collagen, serum or to use surface modification procedures prior to cell seeding to 
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encourage attachment. In vitro cultured SMCs for example have been shown to attach and 
proliferate extensively on a biodegradable polyesterurethane foam, which was pre-treated 
with fetal bovine serum (Danielsson, Ruault et al. 2006) as well as on plasma coated, 
electrospun polystyrene (Baker, Atkin et al. 2006). 
An alternative approach is to combine different scaffold materials with diverse qualities. 
The so called composite scaffolds can be fabricated with two or more completely different 
polymer systems for engineering of hollow organs. Scaffolds designed for hollow organs 
require a special consideration of their barrier function between the cavity and the 
surrounding tissues while accommodating sufficient amounts of cells that facilitate tissue 
development. In recent reports a composite scaffold composed of synthetic PGA and a 
native acellular matrix (collagen) proved to be optimal for the engineering of bladder tissue 
combining the advantages of the different materials (Eberli, Freitas Filho et al. 2009).  
Collagen hybrid matrices have been used with mixed results in vitro. In one study, PLGA 
mesh was combined with collagen and processed to become either a sponge or a gel 
(Nakanishi, Chen et al. 2003). Cultured porcine urothelial and bladder smooth muscle cells 
were seeded onto each of the constructs. Smooth muscle cells were able to proliferate and 
retain expression of differentiation markers when cultured on the on the gel-based 
construct, but not on the sponge. The opposite was the case for urothelial cells, which 
stratified on a sponge but not gel, although unequivocal immunohistochemical markers of 
differentiation were not tested on the urothelium (Nakanishi, Chen et al. 2003). More 
promising were the results of Eberli and colleges (Eberli, Freitas Filho et al. 2009), who used 
a composite scaffolding system of a native acellular collagen matrix bonded to PGA 
polymer meshes. The acellular matrix served as a barrier that would prevent the luminal 
content from permeating into the body cavity while providing an optimal surface for 
epithelial cell adherence and growth. The synthetic polymer layer with large pores was 
designed to accommodate sufficient numbers of muscle cells and maintained structural 
integrity of the scaffold at the same time. The study showed that this composite scaffold 
remained biocompatible, possessed ideal physical and structural characteristics for hollow 
organ applications and formed bladder tissue in vivo (Eberli, Freitas Filho et al. 2009). 
Composite scaffolds seem to be an ideal approach for the TE of hollow organs, meeting the 
demands for a biomaterial addressing the unique needs of the different cells used. 
 
3. Vascularisation and Innervation 
Although many studies demonstrated tissue formation similar to native bladder the 
functionality of these constructs has never been demonstrated. The two main issues limiting 
the constructs to be both contractile and capable of physiologic voiding are proper 
innervation and vascularisation of the tissue engineered construct. 
Rapid neo-vascularisation is essential for graft survival, and complete restoration of the 
organ structure and functionality. The two main mechanisms forming new blood vessels are 
angiogenesis (proliferation and migration of endothelial cells from pre-existing vasculature) 
and vasculogenesis (formation of new vessels by in situ incorporation, differentiation, 
migration and/or proliferation of endothelial progenerator cells recruited from peripheral 
blood). Transplanted matrices relay on vascular ingrowth from the surrounding tissue to 
support previously seeded cells and promote migration of native cells onto the grafted 
region (Pope, Davis et al. 1997, Ko, Milthorpe et al. 2007). 
 
The engineering of large organs will require a vascular network of arteries, veins, and 
capillaries to deliver sufficient nutrients and oxygen to each cell. One possible method to 
artificially induce re-vascularisation in engineered tissue might be through application of 
angiogenic agents such as vascular endothelial growth factors (VEGFs) or the implantation 
of vascular endothelial cells (EC). VEGF is a multifunctional growth factor that functions as 
an inducer of vascular permeability and endothelial cell specific mitogen (Ferrara and 
Davis-Smyth 1997). In addition to its angiogenic function, VEGF also functions as anti-
apoptotic factor for smooth muscle (Yamanaka, Shirai et al. 2002) and endothelial cells 
(Gerber, Dixit et al. 1998). Skeletal myoblasts from adult rats were cultured and transduced 
with an adenovirus encoding VEGF165. These cells were injected into a rat with ischemic 
cardiomyopathy. Neovascularization was assessed histologically four weeks after therapy. 
A significantly greater increase in vascular density was seen in these animals compared to 
the control animals treated with adenoviral VEGF165 alone. These results indicate that a 
combination of VEGF and endothelial cells may be useful for inducing neo-vascularisation 
and volume preservation in engineered tissues (Askari, Unzek et al. 2004). 
As graft shrinkage seems to be a natural process of a scaffold material for a hollow organ, 
enhancement of vascular supply to the graft has been conceived as a measure to sustain the 
viability of regenerated bladder. In bladder augmentation, omental coverage (Oberpenning, 
Meng et al. 1999), application of exogenous angiogenic growth factors (Kanematsu, 
Yamamoto et al. 2003, Kanematsu, Yamamoto et al. 2004, Nomi, Atala et al. 2002) and 
endothelial cell seeding (Schultheiss, Gabouev et al. 2005) were reported to allow ingrowth 
of capillaries to the graft, but may still be lacking the ability to provide a permanent and 
sufficiently robust vascular supply to sustain a large graft for the human bladder. 
Innervation of the regenerated bladder tissue is mandatory for long term functional 
survival of the graft and to avoid secondary degeneration of the smooth muscle. 
Unfortunately, one of the major obstacles in engineering bladders for clinical use has been 
the lack of functional innervation.  
The influence of different neurotrophic factors in neural development, survival, outgrowth 
and branching has been investigated by different research groups (McConnell, Dhar et al. 
2004, Levenberg, Burdick et al. 2005, Sondell, Sundler et al. 2000). Mitsui et al. transplanted 
immortalized neural stem cells, neuronal and glial restricted precursors, or fibroblasts 
expressing neurotrophic factors to contused spinal cord, and reported improved bladder 
function (Mitsui, Shumsky et al. 2005). NGF is the first and best-characterised member of 
the neurotrophin family. NGF supports survival, outgrowth, and branching of sensory and 
autonomic neurons, but does not promote motor neuron regeneration (Kingham and 
Terenghi 2006). Gene therapy for peripheral nerve regeneration has been used by Sasaki et 
al. They injected nerve growth factor (NGF) to the bladder wall with a replication-defective 
adenovirus for the treatment of adult diabetic cystopathy and reported a markedly 
improved bladder function (Sasaki, Chancellor et al. 2004). This viral vector system has 
been shown to restore decreased NGF expression in the bladder. However, increased levels 
of NGF in bladder afferent neurons lead to hyperreflexia, which was significantly reduced 
when NGF levels were neutralized with anti-NGF antibodies (Seki, Sasaki et al. 2002). 
Moreover, high doses of NGF delay nerve regeneration by retarding GAP 43 (Hirata, 
Masaki et al. 2002). Therefore, it is equally important to consider optimal dose and release 
kinetics for the application of such therapeutic growth factors. Glial cell line-derived 
neurotrophic factor (GDNF) is a potent survival factor for motor neurons (Henderson, 
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endothelial cell seeding (Schultheiss, Gabouev et al. 2005) were reported to allow ingrowth 
of capillaries to the graft, but may still be lacking the ability to provide a permanent and 
sufficiently robust vascular supply to sustain a large graft for the human bladder. 
Innervation of the regenerated bladder tissue is mandatory for long term functional 
survival of the graft and to avoid secondary degeneration of the smooth muscle. 
Unfortunately, one of the major obstacles in engineering bladders for clinical use has been 
the lack of functional innervation.  
The influence of different neurotrophic factors in neural development, survival, outgrowth 
and branching has been investigated by different research groups (McConnell, Dhar et al. 
2004, Levenberg, Burdick et al. 2005, Sondell, Sundler et al. 2000). Mitsui et al. transplanted 
immortalized neural stem cells, neuronal and glial restricted precursors, or fibroblasts 
expressing neurotrophic factors to contused spinal cord, and reported improved bladder 
function (Mitsui, Shumsky et al. 2005). NGF is the first and best-characterised member of 
the neurotrophin family. NGF supports survival, outgrowth, and branching of sensory and 
autonomic neurons, but does not promote motor neuron regeneration (Kingham and 
Terenghi 2006). Gene therapy for peripheral nerve regeneration has been used by Sasaki et 
al. They injected nerve growth factor (NGF) to the bladder wall with a replication-defective 
adenovirus for the treatment of adult diabetic cystopathy and reported a markedly 
improved bladder function (Sasaki, Chancellor et al. 2004). This viral vector system has 
been shown to restore decreased NGF expression in the bladder. However, increased levels 
of NGF in bladder afferent neurons lead to hyperreflexia, which was significantly reduced 
when NGF levels were neutralized with anti-NGF antibodies (Seki, Sasaki et al. 2002). 
Moreover, high doses of NGF delay nerve regeneration by retarding GAP 43 (Hirata, 
Masaki et al. 2002). Therefore, it is equally important to consider optimal dose and release 
kinetics for the application of such therapeutic growth factors. Glial cell line-derived 
neurotrophic factor (GDNF) is a potent survival factor for motor neurons (Henderson, 
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Phillips et al. 1994). Variations in GDNF release influenced the rate of functional motor 
nerve recovery in rat primary peripheral nerve repair (Piquilloud, Christen et al. 2007). 
VEGF a potent angiogenetic factor also serves as neurotrophic factor for nerve regeneration 
(Sondell, Sundler et al. 2000). 
Application of multiple growth factors rather than a single factor may hold great promise 
to support target organ innervation. The complex neural mechanism regulating bladder 
function includes various neural subpopulations, which are responsive for different 
neurotrophic factors. For example, lumbar dorsal root ganglion (DRG) neurons were found 
to express 65% Ret and 35% TrkA receptors for GDNF and NGF, respectively and 9% of 
receptors positive for both GDNF and NGF (Kashiba, Hyon et al. 1998). Madduri et al. 
demonstrated the synergistic effect of GNDF and NGF on axonal elongation and branching 
form DRG neurons (Madduri, Papaloizos et al. 2009).  
NGF combined with VEGF enhanced regeneration of bladder acellular matrix grafts in 
spinal cord injury induced neurogenic rat bladders and protein gene product 9.5 (PGP) 
positive nerve fibers were observed most abundantly in the groups treated with combined 
factors rather than single factor treated groups (Kikuno, Kawamoto et al. 2009). However, 
the optimal combination of neurotrophic factors supporting bladder regeneration still 
remains unclear. 
Axonal growth direction is well regulated by topographical features. Longitudinally 
aligned nanofibres guided the axons unidirectionally compared to random fibres, which 
showed axonal growth distributed in all directions (Corey, Lin et al. 2007). 
 
4. Summery and Perspective 
An ideal biomaterial for the engineering of functional bladder should be biocompatible and 
support tissue formation as well as provide adequate structural support to the neo-organ 
during tissue development. Many research groups were able to show tissue formation 
similar to native bladder. However, the functionality of these constructs has never been 
demonstrated.  
The two main issues hampering the tissue engineered constructs to be contractile and allow 
physiologic voiding are proper innervation and vascularisation.  
In near future, tissue engineered scaffolds with controlled topography and multiple neural 
and angiogenetic factors will provide a potential option to introduce proper biological 
function to the engineered artificial bladder. 
 
5. Table 
Natually derived scaffolds 
eg. Bladder submucosa 
+ Mainly collagen, naturally derived 
+ Absorbable 
+ Cell recognition sites 
+ Growth Factors  
- Low elasticity 
- High variability 
Synthetic scaffolds 
eg. PGA 
+ Absorbable 
+ High porosity (up to 95%) 
+ Low variability 
- Synthetic, no recognition sites 
 
Table 1. Comparison between the 2 main classes of biomaterials utilized for TE of hollow 
organs 
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